Page last updated: 2024-09-05

solidagenone and Disease Models, Animal

solidagenone has been researched along with Disease Models, Animal in 5 studies

*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
de Oliveira, TB; do Reis, BPZC; Kelly, AM; Meira, CS; Orge, ID; Santos, IP; Soares, MBP; Valverde, SS; Vasconcelos, JF1
de Oliveira, TB; de Sousa, OV; Gonçalves, GC; Santos, BCS; Valverde, SS1
Alievi, K; de Oliveira Alves, B; Ernetti, J; Locateli, G; Miorando, D; Mota da Silva, L; Müller, LG; Roman Junior, WA; Serpa, PZ; Vecchia, CAD; Zilli, GAL1
Razmilic, I; Rodríguez, JA; Sánchez, M; Schmeda-Hirschmann, G; Theoduloz, C; Yáñez, T1
Astudillo, L; Rodriguez, J; Schmeda-Hirschmann, G1

Other Studies

5 other study(ies) available for solidagenone and Disease Models, Animal

ArticleYear
The protective effect of solidagenone from Solidago chilensis Meyen in a mouse model of airway inflammation.
    Basic & clinical pharmacology & toxicology, 2022, Volume: 130, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Furans; Inflammation; Inflammation Mediators; Lymphocytes; Macrophages; Male; Mice; Mice, Inbred BALB C; Naphthalenes; Ovalbumin; Solidago

2022
Solidagenone from Solidago chilensis Meyen inhibits skin inflammation in experimental models.
    Basic & clinical pharmacology & toxicology, 2021, Volume: 128, Issue:1

    Topics: Acetylglucosaminidase; Animals; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dermatitis; Disease Models, Animal; Edema; Furans; Hydrogen Bonding; Hydroxyprostaglandin Dehydrogenases; Interleukin-6; Male; Membrane Proteins; Mice; Molecular Docking Simulation; Naphthalenes; Nitric Oxide; Peroxidase; Plant Extracts; Protein Binding; Signal Transduction; Skin; Solidago; Tumor Necrosis Factor-alpha

2021
Antidepressant-like effects of solidagenone on mice with bacterial lipopolysaccharide (LPS)-induced depression.
    Behavioural brain research, 2020, 10-01, Volume: 395

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Depression; Disease Models, Animal; Furans; Interleukin-1beta; Lipopolysaccharides; Male; Mice; Naphthalenes; Oxidative Stress; Signal Transduction; Tumor Necrosis Factor-alpha

2020
Gastroprotective activity of a new semi-synthetic solidagenone derivative in mice.
    The Journal of pharmacy and pharmacology, 2005, Volume: 57, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Animals; Anti-Ulcer Agents; Cell Line; Cell Proliferation; Chile; Dinoprostone; Disease Models, Animal; Diterpenes; Drug Evaluation, Preclinical; Epithelium; Ethanol; Fibroblasts; Furans; Gastric Mucosa; Humans; Hydrochloric Acid; Inhibitory Concentration 50; Lansoprazole; Lung; Mice; Naphthalenes; Neutral Red; Omeprazole; Stomach Ulcer; Tetrazolium Salts

2005
Gastroprotective activity of the diterpene solidagenone and its derivatives on experimentally induced gastric lesions in mice.
    Journal of ethnopharmacology, 2002, Volume: 81, Issue:1

    Topics: Animals; Anti-Ulcer Agents; Biotransformation; Disease Models, Animal; Diterpenes; Ethanol; Furans; Hydrochloric Acid; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Naphthalenes; Phytotherapy; Solidago; Stomach Diseases; Stomach Ulcer

2002